These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 8741750

  • 1. Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia.
    Banerjee SP, Zuck LG, Yablonsky-Alter E, Lidsky TI.
    Neuroreport; 1995 Dec 15; 6(18):2500-4. PubMed ID: 8741750
    [Abstract] [Full Text] [Related]

  • 2. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
    Schwieler L, Linderholm KR, Nilsson-Todd LK, Erhardt S, Engberg G.
    Life Sci; 2008 Aug 01; 83(5-6):170-5. PubMed ID: 18590745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.
    Spurney CF, Baca SM, Murray AM, Jaskiw GE, Kleinman JE, Hyde TM.
    Synapse; 1999 Dec 15; 34(4):266-76. PubMed ID: 10529721
    [Abstract] [Full Text] [Related]

  • 5. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL, Wang RY.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1000-6. PubMed ID: 10215680
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH, Levin ED.
    Eur J Pharmacol; 2004 Feb 20; 486(2):175-82. PubMed ID: 14975706
    [Abstract] [Full Text] [Related]

  • 9. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ, Brocco M, Rivet JM, Audinot V, Newman-Tancredi A, Maiofiss L, Queriaux S, Despaux N, Peglion JL, Dekeyne A.
    J Pharmacol Exp Ther; 2000 Jan 20; 292(1):54-66. PubMed ID: 10604931
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 20; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun 20; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 15. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
    Heresco-Levy U.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct 20; 27(7):1113-23. PubMed ID: 14642971
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 20; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 18. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol.
    Millan MJ, Brocco M, Gobert A, Schreiber R, Dekeyne A.
    J Pharmacol Exp Ther; 1999 Mar 20; 288(3):1002-14. PubMed ID: 10027837
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M, Zoli M, Mazzoncini R, Gennarelli M, Spano F.
    Psychopharmacology (Berl); 2001 Dec 20; 159(1):105-10. PubMed ID: 11797077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.